Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Heavy Insider Buying at Bank of America Corp (BAC) and Two Other Struggling Companies

Page 1 of 2

All major U.S. stock indexes gained more than 1% on Monday, on the back of diminishing worries about the health of the U.S. economy and recovering crude oil prices. The Dow Jones Industrial Average gained 228.67 points or 1.4% in the first trading session of this week, closing at 16,620.66. In fact, 29 of the 30 Dow components closed in the green on Monday, pushing the gauge into positive territory for February. Insider buying activity has been escalating in recent weeks, which coupled with optimistic U.S. economic data might represent a really positive sign for investors. Investors are becoming less concerned about mounting tales about a potential slowdown of the U.S. economy, which has woken up a strong appetite for U.S. equities once again. The Insider Monkey team looked through dozens of Form 4 filings submitted with the SEC on Monday and identified three companies with noteworthy insider buying, so this article will solely discuss the insider trading behavior and performance of those three companies.

Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that imitating the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012 (read more details here).

To start with, Bank of America Corp (NYSE:BAC) has seen two insiders purchase shares over the past week or so. Thong M. Nguyen, President of Retail Banking and Co-head of Consumer Banking, purchased 30,000 shares on Monday at a cost of $12.43 per share and lifted his overall holding to 40,035 shares. Director Frank P. Bramble Sr. bought a new stake of 75,000 shares last Tuesday at $12.32 apiece. The Director also holds an indirect ownership stake of 111,680 shares, which is owned by a revocable trust. Bank stocks have had a tough start to 2016, as investors have been jettisoning these stocks on worries about slowing economic growth, plummeting energy prices and a potential halt in the Fed’s tightening monetary policy. The broader market selloff has hit big banks, including Bank of America Corp (NYSE:BAC), particularly hard thus far in 2016; BAC shares are down 25% since the beginning of the year. Bank of America currently has a market value that is significantly below its book value, which is a strong reason for buying the stock at the moment. In fact, Bank of America is the cheapest big bank in the industry at the moment, save for Citigroup Inc. (NYSE:C). Furthermore, the stock trades at a forward P/E multiple of only 7.49, which is significantly below the average of 11.6 for the Financial sector. At the end of January, Sandler O’Neil upgraded Bank of America’s stock to ‘Buy’ from ‘Hold’. The hedge fund sentiment towards the stock was positive in the fourth quarter of 2015, as the number of money managers tracked by Insider Monkey bullish on the bank increased to 112 from 108 quarter-on-quarter. Boykin Curry’s Eagle Capital Management upped its position in Bank of America Corp (NYSE:BAC) by 4% during the December quarter to 31.64 million shares.

Follow Bank Of America Corp (NYSE:BAC)
Trade (NYSE:BAC) Now!

Let’s head to the second page of this article, where we discuss the insider trading activity witnessed at Overstock.com Inc. (NASDAQ:OSTK) and Covanta Holding Corp (NYSE:CVA).

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!